Education

Fellowship
Psychiatry, UCLA Neuropsychiatric Hospital, 1986
Residency
Psychiatry, UCLA Neuropsychiatric Hospital, 1984
Internship
Psychiatry, UCLA School of Medicine, 1981
Degree
MD, Baylor College of Medicine, 1980

Medical Board Certifications

Psychiatry
American Board of Psychiatry and Neurology, 1986

State License

A37496
  • About Me

    About Me

    Dr. Leuchter is Professor of Psychiatry, Director of the Laboratory of Brain, Behavior, and Pharmacology (LBBP), and a Senior Research Scientist at the Semel Institute for Neuroscience and Human Behavior and the Brain Research Institute at UCLA. He has over 25 years of continuous Federal funding including R0I, K02, and T32 awards, and has been PI on numerous NIH and industry grants to study biomarkers in depression. He was the Principal Investigator for the BRITE-MD study, the largest and most successful neurophysiologic biomarker-focused clinical trial in MDD. He is an expert on differentiating between placebo and medication response in MDD: his group was the first to report brain functional changes associated with the placebo response, neurophysiologic differences between placebo and drug responders, as well as genetic polymorphisms associated with placebo response. He was the Regional Center Director for the Los Angeles site for STAR*D and for the NIMH-funded Depression Trials Network.

    Dr.Leuchter has extensive experience with administration of single- and multi-site clinical trials. As a Board certified electroencephalographer, he has special expertise in interpretation of neurophysiologic data. His work has involved development of neurophysiologic biomarkers for diagnosis, monitoring disease status, and predicting course of illness in dementia, MDD, Huntington’s disease, and most recently autism.
  • Locations
    Address
    760 Westwood Plaza
    Room 57-456
    Los Angeles, California 90095
    Phone
    310-825-0207
    Fax
    310-825-7642
  • Education

    Medical Board Certifications

    Psychiatry
    American Board of Psychiatry and Neurology, 1986

    Education

    Fellowship
    Psychiatry, UCLA Neuropsychiatric Hospital, 1986
    Residency
    Psychiatry, UCLA Neuropsychiatric Hospital, 1984
    Internship
    Psychiatry, UCLA School of Medicine, 1981
    Degree
    MD, Baylor College of Medicine, 1980
  • Research

    Publications

  • News & Awards

    Awards

    • Award for Outstanding Research, June 1996, UCLA Research Conference on Aging. “NGF in Rats with Nucleus Basalis Lesions: Cholinergic and Quantitative Electroencephalographic Correlates,” Holschneider DP, Leuchter AF, Walton NY, Scremin OU, Treiman DM
    • Outstanding Research Mentor Award, UCLA Department of Psychiatry & Biobehavioral Sciences, 1996
    • Early Career Research Award, American Psychiatric Electrophysiology Association, 1997
    • Fellow, American Psychiatric Association, 2000
    • Member, Mental Disorders of Aging Review Committee, National Institute of Mental Health, 1998 - 2000
    • Ad hoc grant reviewer, National Center for Complementary and Alternative Medicine, National Institutes of Health, 2003 – 2008
    • Grant reviewer, Conte Center Study Section, National Institutes of Mental Health, 2009 - 2010
    • Invited presenter, “Brain Mechanisms in the Placebo Response,” Workshop sponsored by the National Institute of Mental Health and the Mind, Brain, Body, and Health Initiative. September 27 – 28, 2004
    • Invited presenter, "Using Biomarkers to Change the Way We Treat Depression,” Harold Visotsky, M.D. Memorial Lecture at Northwestern University Grand Rounds. April 25, 2007
    • Invited presenter, “Evidence-based Approaches to Neurophysiologic Testing in Depression,” 20th Anniversary Conference of the International Society for Neuroimaging in Psychiatry (ISNIP), September 13, 2008, Frankfurt, Germany
    • Invited presenter, North American Research Conference on Complementary and Integrative Medicine, National Center for Complementary and Alternative Medicine, Wednesday, May 13, 2009, Washington, DC
    • Invited presenter, University of Wisconsin School of Medicine and Public Health Psychiatric Update, October 23, 2009, Madison, WI
    • Invited presenter, 5th Annual HD Therapeutics Conference, CHDI, Inc., February 9, 2010, Palm Springs, CA
    • Invited presenter, XXVII CINP World Congress, CINP (International College of Neuropsychopharmacology), June 6- 7, 2010, Hong Kong, SAR